Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2023-02-02 00:00:00 ET · period of report 2023-02-01 · accession 0001127602-23-003172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-02-02 | 2022-12-29 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | G - Gift | $0.00 | +10.0K | 10.0K | New | $0 |
| D | 2023-02-02 | 2023-02-01 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | M - OptEx | $5.45 | +100.0K | 1.11M | +10% | +$545.0K |
| D | 2023-02-02 | 2023-02-01 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | S - Sale+OE | $10.38 | -100.0K | 1.01M | -9% | -$1.04M |
| D | 2023-02-02 | 2022-12-29 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 1.01M | -1.0% | $0 |
| D | 2023-02-02 | 2023-02-01 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | M - OptEx | $0.00 | -100.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-29 | G | A | 5,000 | $0.00 | 10,000 | I By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust | — | — | |
| 2 | Common | Common Stock | 2022-12-29 | G | A | 5,000 | $0.00 | 10,000 | I | — | — | |
| 3 | Common | Common Stock | 2023-02-01 | M | A | 100,000 | $5.45 | 1,108,739 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-01 | S | D | 100,000 | $10.38 | 1,008,739 | D | — | — | (F3) The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.22 to $10.65. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2022-12-29 | G | D | 10,000 | $0.00 | 1,008,739 | D By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust | — | — | |
| 6 | Derivative | Emp. Stock Option (Right to Buy) | 2023-02-01 | M | D | 100,000 | $0.00 | 0 | D | $5.45 · — to 2023-08-08 | 100,000 Common Stock | (F4) The options vested upon the achievement of performance-based vesting criteria with respect to 25,000 shares on each of May 26, 2014, December 19, 2014, May 13, 2015 and December 3, 2020. |